Job for Pharmacist (17 posts) at Health Services - Government job
Online applications are invited from eligible candidates for class-c recruitment under Deputy Director, Health Services, Nashik Board, Nashik
U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma. This indication is approved under accelerated approval based on progression-free survival (PFS). Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.